252 related articles for article (PubMed ID: 15569113)
1. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Bochenek WJ; Mack ME; Fraga PD; Metz DC
Aliment Pharmacol Ther; 2004 Nov; 20(10):1105-14. PubMed ID: 15569113
[TBL] [Abstract][Full Text] [Related]
2. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
5. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Haag S; Holtmann G
Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
[TBL] [Abstract][Full Text] [Related]
6. Prevention of erosive oesophagitis relapse with pantoprazole.
Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
[TBL] [Abstract][Full Text] [Related]
7. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
Richter JE; Bochenek W
Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
[TBL] [Abstract][Full Text] [Related]
8. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
[TBL] [Abstract][Full Text] [Related]
9. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.
Scholten T; Dekkers CP; Schütze K; Körner T; Bohuschke M; Gatz G
Digestion; 2005; 72(2-3):76-85. PubMed ID: 16113546
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
Madan K; Ahuja V; Kashyap PC; Sharma MP
Dis Esophagus; 2004; 17(4):274-8. PubMed ID: 15569362
[TBL] [Abstract][Full Text] [Related]
11. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
12. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.
Pilotto A; Leandro G; Franceschi M; Bierti L; Di Battista R; Notarbartolo A; Pisciotta G; Grassi A; Crestani B; Tafner G; Michelagnoli S; Garotta F
Hepatogastroenterology; 1999; 46(25):245-51. PubMed ID: 10228801
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
Paré P; Armstrong D; Pericak D; Pyzyk M
J Clin Gastroenterol; 2003 Aug; 37(2):132-8. PubMed ID: 12869883
[TBL] [Abstract][Full Text] [Related]
14. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.
Calleja JL; Suarez M; De Tejada AH; Navarro A;
Dig Dis Sci; 2005 Mar; 50(3):432-9. PubMed ID: 15810621
[TBL] [Abstract][Full Text] [Related]
16. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Adamek RJ; Behrendt J; Wenzel C
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
[TBL] [Abstract][Full Text] [Related]
17. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.
Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Eklund S;
Aliment Pharmacol Ther; 2005 Mar; 21(6):739-46. PubMed ID: 15771760
[TBL] [Abstract][Full Text] [Related]
19. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
Dupas JL; Houcke P; Samoyeau R;
Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
